Waverton Investment Management’s HCA Healthcare HCA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-143,647
Closed -$61.2M 42
2025
Q3
$61.2M Buy
143,647
+30,341
+27% +$11.8M 0.79% 27
2025
Q2
$43.4M Buy
113,306
+166
+0.1% +$59.8K 0.6% 32
2025
Q1
$39.2M Hold
113,140
0.61% 37
2024
Q4
$34M Sell
113,140
-46,242
-29% -$16.2M 0.54% 37
2024
Q3
$64.8M Buy
159,382
+17,968
+13% +$6.58M 1.06% 27
2024
Q2
$45.4M Buy
141,414
+13,448
+11% +$4.37M 0.86% 28
2024
Q1
$42.7M Buy
127,966
+11,634
+10% +$3.56M 0.89% 28
2023
Q4
$31.5M Hold
116,332
0.76% 29
2023
Q3
$28.6M Sell
116,332
-290
-0.2% -$79.4K 0.83% 30
2023
Q2
$35.4M Buy
116,622
+49,142
+73% +$13.7M 1.01% 27
2023
Q1
$17.8M Sell
67,480
-240
-0.4% -$61K 0.55% 37
2022
Q4
$16.3M Buy
67,720
+17,858
+36% +$4M 0.6% 35
2022
Q3
$9.16M Sell
49,862
-1,663
-3% -$331K 0.37% 40
2022
Q2
$8.66M Buy
51,525
+10,284
+25% +$2.21M 0.34% 44
2022
Q1
$10.3M Buy
41,241
+8,241
+25% +$2.07M 0.35% 42
2021
Q4
$8.48M Buy
+33,000
New +$8.08M 0.27% 47

Other funds holding HCA

Waverton Investment Management's HCA Position: Q4 2025 in Review

Waverton Investment Management sold out of HCA Healthcare (HCA) in Q4 2025, closing a stake of 143,647 shares — an estimated $61.2M sold.

Waverton Investment Management first reported a position in HCA in Q4 2021 and held it in 16 quarters. The position peaked at $64.8M in Q3 2024. 1,396 funds tracked by Wall St. Rank hold HCA as of Q4 2025.

  • Waverton Investment Management reported no remaining HCA Healthcare position as of Q4 2025 after selling out during the quarter.
  • Waverton Investment Management sold 143,647 HCA Healthcare shares in Q4 2025, an estimated $61.2M.
  • Waverton Investment Management first reported a position in HCA Healthcare in Q4 2021 and held it in 16 quarters.
  • Waverton Investment Management's HCA Healthcare position peaked at $64.8M in Q3 2024.
  • 1,396 funds tracked by Wall St. Rank held HCA Healthcare as of Q4 2025.

Based on Waverton Investment Management's 13F filing for Q4 2025.